Latest filing published 23 Mar 2021 for Keysight Technologies, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Paul N. Clark across 6 companies, led by Agilent Technologies, Inc., Keysight Technologies, Inc. and Biolase, Inc. We count 92 filings; the first trade dates from 24 January 2006 and the latest from 19 March 2021.
Both buying and selling appear: 12 purchases worth €1.6M, against 5 sales worth €2.2M. Netting one side against the other leaves €579k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 65 share grants and 6 option exercises.
The median purchase comes to €7,826.
The newest entry dates from 23 March 2021: a share grant, in Keysight Technologies, Inc. The last insider purchase was made public on 12 November 2015, 3,998 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 77 declarations